SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mts362 who wrote (852)4/4/2000 9:40:00 AM
From: david james  Read Replies (1) of 1298
 
The CEO had previously stated that it would take 135 years to use their current cash at the current burn rate. The should have close to $50 mill in revs from licenses which is close to their burn rate. And if they didn't use their cash, they would collect another $15 mill in interest. That would likely make them profitable each quarter.

However, they plan on spending that cash to get a late stage product that will provide revenues greater than that $15 mill. And within a few months, they may be asking the FDA to approve a lung cancer or prostate cancer vaccine.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News